This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 10 mL vials of the injectable pain medication Nalbuphine. The contract, valued at $1,241.29, is a firm fixed-price delivery order with a completion date of December 10, 2024.
AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract awarded encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There was no set-aside designation for this contract award.
Generated 3/16/25, 12:48 AM